Immunotherapy and Personalised Cancer Vaccines: Integrating with Repurposed Drugs (2025)
In 2025, the landscape of cancer treatment is evolving rapidly, with personalized cancer vaccines and advanced immunotherapy emerging as game-changers in oncology. These therapies harness the body's immune system to target tumors with unprecedented precision, offering hope for patients with hard-to-treat cancers like pancreatic, lung, and colorectal. Personalized vaccines are now being tailored to individual tumors, identifying unique neoantigens to train the immune system against cancer cells while minimizing damage to healthy tissue. Meanwhile, antibody-drug conjugates (ADCs) are revolutionizing targeted therapy by delivering potent payloads directly to cancer cells. In this article, we explore how these cutting-edge immunotherapies can synergize with repurposed drugs such as ivermectin, fenbendazole, and mebendazole—affordable, off-label options with growing evidence in cancer care. This article dives into the science, breakthroughs, and practical integration strategies, providi...